Nutex Health (NUTX) Revenue (2010 - 2026)

Nutex Health (NUTX) has 17 years of Revenue data on file, last reported at $216.5 million in Q1 2026.

• Quarterly Revenue rose 2.22% year-over-year to $216.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $880.0 million (up 40.95% YoY) and the FY2025 annual result came in at $875.3 million, up 82.36% from the prior year.
• Revenue climbed to $216.5 million in Q1 2026 per NUTX's latest filing, from $151.7 million in the prior quarter.
• The five-year high for Revenue was $267.8 million in Q3 2025, with the low at $28.4 million in Q3 2022.
• Average Revenue over 5 years is $119.9 million, with a median of $76.1 million recorded in 2024.
• The widest YoY moves for Revenue: up 3828.19% in 2022, down 75.93% in 2022.
• Nutex Health's Revenue stood at $53.7 million in 2022, then gained by 29.68% to $69.7 million in 2023, then soared by 269.77% to $257.6 million in 2024, then plunged by 41.12% to $151.7 million in 2025, then jumped by 42.73% to $216.5 million in 2026.
• Business Quant data shows NUTX's Revenue at $216.5 million in Q1 2026, $151.7 million in Q4 2025, and $267.8 million in Q3 2025.